see more

Third-generation contraceptive pills are displayed on January 2, 2013 in Lille, in northern France. France's national drug agency ANSM started consultations with prescribers of third-generation contraception pills on January 2 to try to limit the use of such pills which are subject to complaints, after a French woman attributed her stroke to her contraception pill in mid-December 2012. Some 13,500 complaints were also lodged in the US against Bayer's four-generation Yaz contraceptive pill. AFP PHOTO PHILIPPE HUGUEN / AFP PHOTO / Philippe HUGUEN (Photo credit should read PHILIPPE HUGUEN/AFP via Getty Images)

Third-generation contraceptive pills are displayed on January 2, 2013 in Lille, in northern France. France's national drug agency ANSM started consultations with prescribers of third-generation contraception pills on January 2 to try to limit the use of such pills which are subject to complaints, after a French woman attributed her stroke to her contraception pill in mid-December 2012. Some 13,500 complaints were also lodged in the US against Bayer's four-generation Yaz contraceptive pill.  AFP PHOTO PHILIPPE HUGUEN / AFP PHOTO / Philippe HUGUEN        (Photo credit should read PHILIPPE HUGUEN/AFP via Getty Images)